Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122454) titled 'Predicting the progressive adverse events of intracerebral hemorrhage through interpretable AI-driven spatiotemporal evolution of the environment' on April 14.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

Condition: Cerebral hemorrhage

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-05-01

Target Sample Size: Observation group:1000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=302796

Disclaimer: Curated by HT Syndication....